Risk factors

Palantir faces significant risks from lengthy sales cycles, complex AI platform deployments, and reliance on key leadership under CEO Alexander Karp. The company navigates intense competition, strict government contracting standards, and stringent data privacy regulations globally.

Heavy reliance on Title IV federal student financial aid and related regulatory compliance dominates risk exposure.

Transocean operates in the cyclical offshore drilling industry, dependent on volatile oil and gas prices and exploration spending.

Rithm Capital relies heavily on mortgage servicing rights, asset management growth including Sculptor, leverage, and financing counterparties.

Rithm Property Trust relies heavily on external management and faces concentrated risks in mortgage and commercial real estate assets. The company incurred a $92.2 million net loss in 2024 and suffers from asset illiquidity and credit deterioration.

Seven Hills Realty Trust relies entirely on manager Tremont and RMR for operations and investment decisions under a related-party structure. The company focuses heavily on commercial real estate bridge loans, financing them via master repurchase agreements subject to margin calls. Portfolio concentration in a limited number of loans and exposure to interest rate fluctuations dominate risks.

Our business is heavily concentrated in midtown Manhattan commercial office properties, exposing us to regional economic shifts.

The risk profile is dominated by operational, legal, and financial fallout from the Çöpler Incident in Türkiye. Company operations, liquidity, debt covenants, and share price face severe uncertainty due to ongoing investigations and suspended operations. Exposure to metal prices, reserve replacement, and jurisdiction-specific regulatory changes compound overall business risks.

Star Holdings faces substantial asset concentration, with two properties comprising 63% of legacy portfolio value. Real estate sales and developments drive cash flow generation strategies. Leverage, margin loans, and debt maturities in 2026 create significant financial vulnerability.

The company relies heavily on large retail customers and international sourcing, exposing it to global supply chain and trade risks.

Beer-market change and consumer shifts make premiumization, innovation beyond beer, and brand strength central to growth.

Medicare reimbursement changes and pricing pressure heavily impact our lymphedema product revenues. Stringent FDA, health care compliance, and single-source supplier dependencies dominate our risk profile.